The Jackson Laboratory: Clinical Trials

6 trials sponsored by The Jackson Laboratory, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 enrolling by invitation. 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 1, Enrolling by invitation 1
Phase 42Active not recruiting 1, Completed 1

Follow The Jackson Laboratory: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
Flu Vaccine (Year 1), Flu Vaccine (Year 2), Flu Vaccine (Year 3) - Aging, Influenza Vaccine
Phase 4Active not recruitingThe Jackson Laboratory752022-08-312026-08-03
Uncovering the Etiologies of Non-immune Hydrops Fetalis
Whole genome sequencing - Non-Immune Hydrops Fetalis
Not applicableEnrolling by invitationUniversity of California, San Francisco5002022-03-012026-04-17
Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children
COVID-19, SARS-CoV-2
CompletedConnecticut Children's Medical Center4722020-05-152025-04-01
Prenatal Genetic Diagnosis by Genomic Sequencing
Prenatal Genomic Sequencing - Fetal Structural Anomalies
CompletedColumbia University10972019-06-282025-10-27
Ellagic Acid, Urolithin and Colonic Microbial Communities Affected by Walnut Consumption
Walnuts - Colo-rectal Cancer, Colon Cancer
Not applicableCompletedUConn Health472019-05-202021-11-26
Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
Pneumococcal 13valent Conj Vaccine Diphtheria CRM197 Protein, Pneumococcal Vaccine Polyvalent - Pneumonia, Aging
Phase 4CompletedThe Jackson Laboratory402017-04-172025-08-22

Conditions studied

COVID-19 (1)  ·  Colonic Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Feeding Behavior (1)  ·  Hydrops Fetalis (1)  ·  Inflammatory Bowel Diseases (1)  ·  Influenza, Human (1)  ·  Pneumonia (1)

Interventions

13-valent pneumococcal vaccine (1)  ·  23-valent pneumococcal capsular polysaccharide vaccine (1)  ·  Influenza Vaccines (1)  ·  Pneumococcal Vaccines (1)

Countries

United States (6)

Top investigators

George Kuchel, M.D. F.R.C.P (1)  ·  George Kuchel, MD, FRCP (1)  ·  Jeffrey Hyams, MD (1)  ·  Ronald Wapner, MD (1)  ·  Teresa Sparks, MD (1)

Results publications

PMID 37131707

NIH funding

R01HD055651 (1), R01HD107190 (1), U01AI165452 (1)